Rocket Doctor AI to Present at the 2025 CANTech Letter Conference in Toronto
Rocket Doctor AI (CSE: AIDR) announced its participation in the upcoming CANTech Letter Investment Conference on October 9, 2025, in Toronto, Ontario. CEO Dr. Essam Hamza and Rocket Doctor Inc. Founder Dr. William Cherniak will present at 2:30 PM ET in Track 1.
The presentation will showcase the company's healthcare technology platform, which focuses on AI-powered solutions for improving healthcare accessibility. The executives will discuss platform innovations, recent milestones, and growth strategy during their 30-minute session.
Rocket Doctor AI (CSE: AIDR) ha annunciato la sua partecipazione alla prossima CANTech Letter Investment Conference il 9 ottobre 2025 a Toronto, Ontario. Il CEO, il dottor Essam Hamza, e il fondatore di Rocket Doctor Inc., il dottor William Cherniak, interverranno alle 14:30 ET nel Track 1.
La presentazione metterà in luce la piattaforma tecnologica sanitaria dell’azienda, focalizzata su soluzioni basate sull’IA per migliorare l’accessibilità alle cure.Gli executive discuteranno delle innovazioni della piattaforma, dei traguardi recenti e della strategia di crescita durante la sessione di 30 minuti.
Rocket Doctor AI (CSE: AIDR) anunció su participación en la próxima CANTech Letter Investment Conference el 9 de octubre de 2025 en Toronto, Ontario. El director ejecutivo, el Dr. Essam Hamza, y el fundador de Rocket Doctor Inc., el Dr. William Cherniak, presentarán a las 14:30 ET en la Pista 1.
La presentación mostrará la plataforma tecnológica de atención sanitaria de la empresa, centrada en soluciones impulsadas por IA para mejorar la accesibilidad a la atención médica. Los ejecutivos discutirán las innovaciones de la plataforma, hitos recientes y la estrategia de crecimiento durante su sesión de 30 minutos.
Rocket Doctor AI (CSE: AIDR)가 다가오는 CANTech Letter Investment Conference에 2025년 10월 9일 토론토, 온타리오에서 참가를 발표했습니다. CEO인 Essam Hamza 박사와 Rocket Doctor Inc. 설립자 William Cherniak 박사는 동부 표준시 14:30에 트랙 1에서 발표할 예정입니다.
발표는 회사의 AI 기반으로 의료 접근성을 개선하는 데 중점을 둔 헬스케어 기술 플랫폼을 선보일 것입니다. 경영진은 30분 세션 동안 플랫폼의 혁신, 최근 이정표 및 성장 전략에 대해 논의할 것입니다.
Rocket Doctor AI (CSE: AIDR) a annoncé sa participation à la prochaine conférence CANTech Letter Investment Conference le 9 octobre 2025 à Toronto, Ontario. Le PDG, le Dr Essam Hamza, et le fondateur de Rocket Doctor Inc., le Dr William Cherniak, interviendront à 14h30 HE sur Track 1.
La présentation présentera la plateforme technologique de santé de l’entreprise, axée sur des solutions alimentées par l’IA pour améliorer l’accessibilité aux soins. Les dirigeants discuteront des innovations de la plateforme, des étapes récentes et de la stratégie de croissance lors de leur séance de 30 minutes.
Rocket Doctor AI (CSE: AIDR) hat seine Teilnahme an der kommenden CANTech Letter Investment Conference am 9. Oktober 2025 in Toronto, Ontario, angekündigt. CEO Dr. Essam Hamza und der Gründer von Rocket Doctor Inc., Dr. William Cherniak, werden um 14:30 ET im Track 1 präsentieren.
Die Präsentation wird die Gesundheits- technologische Plattform des Unternehmens vorstellen, die sich auf KI-gestützte Lösungen zur Verbesserung des Zugangs zu Gesundheitsleistungen konzentriert. Die Führungskräfte werden während ihrer 30-minütigen Sitzung über Plattform-Innovationen, jüngste Meilensteine und Wachstumsstrategie sprechen.
Rocket Doctor AI (CSE: AIDR) أعلن عن مشاركته في مؤتمر CANTech Letter Investment Conference القادم في 9 أكتوبر 2025 في تورونتو، أونتاريو. سيقدم الرئيس التنفيذي الدكتور عصام حمزة ومؤسس Rocket Doctor Inc. الدكتور وليام أيشنيك عرضه في الساعة 2:30 مساءً بتوقيت شرق الولايات المتحدة في المسار 1.
ستعرض الجلسة منصة تكنولوجيا الرعاية الصحية للشركة، التي تركز على حلول مدعومة بالذكاء الاصطناعي لتحسين إمكانية الوصول إلى الرعاية الصحية. سيناقش التنفيذيون ابتكارات المنصة، والإنجازات الأخيرة، واستراتيجية النمو خلال جلستهم التي تستغرق 30 دقيقة.
Rocket Doctor AI (CSE: AIDR) 宣布将参加将于 2025年10月9日 在多伦多安大略省举行的 CANTech Letter Investment Conference。首席执行官 Essam Hamza 博士以及 Rocket Doctor Inc. 创始人 William Cherniak 博士将于 东部时间下午2:30 在 Track 1 进行演讲。
此次演讲将展示公司以 AI 驱动的健康科技平台，专注于改善医疗可及性的解决方案。高管们将在这场为期30分钟的会议中讨论平台创新、近期里程碑及增长策略。
- None.
- None.
- Rocket Doctor AI CEO, Dr. Essam Hamza and Rocket Doctor Inc. Founder & CEO, Dr. William Cherniak to present live at 2:30 PM ET in Track 1 on October 9, 2025.
- Presentation will highlight Rocket Doctor AI’s platform innovations, recent milestones, and growth strategy.
- Attendees can register and learn more at conference.cantechletter.com/
TORONTO, Ontario, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) a healthcare technology company focused on delivering physician-built, AI-powered solutions designed to make high-quality healthcare accessible throughout the entire patient journey, is pleased to announce its participation at the upcoming CANTech Letter Investment Conference on Thursday, October 9, 2025, in Toronto, Ontario. Rocket Doctor AI’s CEO, Dr. Essam Hamza, and Founder & CEO of Rocket Doctor Inc., Dr. William Cherniak, will present an overview of the company’s platform, solutions, recent milestones, and growth strategy.
2025 CANTech Letter Conference
Date: Thursday, October 9, 2025
Time: 2:30–3:00 PM Eastern Time in Track 1
Location: Toronto, Ontario (venue as listed by conference organizers)
Contact: Please register via the conference website
More info: https://conference.cantechletter.com/
Dr. Essam Hamza commented, “CANTech brings together Canada’s most engaged technology investors and operators. Dr. Bill Cherniak and I are excited to share how Rocket Doctor AI is deploying clinician-led, pragmatic AI platforms to streamline workflows, reduce administrative friction, and ultimately improve patient access and outcomes.”
Attendees of the 2025 CANTech Letter Conference can join the Rocket Doctor AI session in Track 1 at 2:30 PM ET. For event details and registration, please visit the conference website.
About Rocket Doctor AI Inc.
Rocket Doctor AI Inc. delivers physician-built, AI-powered solutions designed to make high-quality healthcare accessible throughout the entire patient journey. A cornerstone of the company’s proprietary technology is the Global Library of Medicine (GLM), a clinically validated decision support system developed with input from hundreds of physicians worldwide.
Alongside the GLM is Rocket Doctor Inc, and its AI-powered digital health platform and marketplace. Having helped empower over 300 MDs to provide care to more than 700,000 patient visits, our proprietary technology software and systems enable doctors to independently launch and manage their own virtual or hybrid in-person practices - improving efficiency, restoring autonomy to MDs, and expanding patient access to care.
By reducing administrative burdens and ensuring greater consistency in care, our technology creates more time for meaningful physician-patient interactions. We are committed to reaching underserved, rural, and remote communities in Canada who often lack access to family doctors and supporting patients on Medicaid and Medicare in the United States. With advanced AI, large language models, and connected medical devices, Rocket Doctor AI is redefining modern healthcare - making it more scalable, equitable, and patient-centered.
To learn more about Rocket Doctor AI Inc’s products and services, contact:
www.rocketdoctor.ai or email: info@rocketdoctor.ai
FOR ADDITIONAL INFORMATION, CONTACT:
Dr. Essam Hamza, CEO, Rocket Doctor AI
essam.hamza@rocketdoctor.ai
Dr. Bill Cherniak, CEO, Rocket Doctor Inc.
bill@rocketdoctor.io
For media inquiries, contact: media@rocketdoctor.ai
Call: +1 (778) 819 8321
Cautionary Statements
This news release contains forward-looking statements relating to the future operations of Rocket Doctor AI Inc. and other statements that are not historical facts. Forward-looking statements are often identified by terms such as "will", "may", "should", "anticipate", "expects" and similar expressions. All statements other than statements of historical fact, included in this release, including, without limitation, statements regarding the Offering, the use of proceeds of the Offering, the filing of a Prospectus Supplement and future plans and objectives of Rocket Doctor AI Inc., are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from Rocket Doctor AI Inc.'s expectations include other risks detailed from time to time in the filings made by Rocket Doctor AI Inc. with securities regulators.
The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of Rocket Doctor AI Inc. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and Rocket Doctor AI Inc. will only update or revise publicly the included forward-looking statements as expressly required by Canadian securities law.
FAQ
When and where is Rocket Doctor AI presenting at the 2025 CANTech Letter Conference?
Who will be presenting for Rocket Doctor AI at the CANTech Letter Conference?
What will Rocket Doctor AI (CSE: AIDR) discuss at the CANTech Letter Conference?
How can investors attend Rocket Doctor AI's presentation at the CANTech Letter Conference?
